Glaxosmithkline announced collaboration with Chroma Therapeutics to develop
macrophage-targeted compounds. Chroma has the potential to receive in excess of $1 billion in total milestone and option payments from GSK. Chroma will receive a significant upfront cash payment and GSK will invest in Chroma's Series D equity financing.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Compelling solutions through strategic partnerships
Ineos CEO Ineos calls on European politicians to save the chemical industry.
